Cargando…

Current and Novel Inhibitors of HIV Protease

The design, development and clinical success of HIV protease inhibitors represent one of the most remarkable achievements of molecular medicine. This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, sid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pokorná, Jana, Machala, Ladislav, Řezáčová, Pavlína, Konvalinka, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185513/ https://www.ncbi.nlm.nih.gov/pubmed/21994591 http://dx.doi.org/10.3390/v1031209

Ejemplares similares

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor
por: Schimer, Jiří, et al.
Publicado: (2015)

Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus
por: Pokorná, Jana, et al.
Publicado: (2018)

DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors
por: Kožíšek, Milan, et al.
Publicado: (2018)

Viral proteases as therapeutic targets
por: Majerová, Taťána, et al.
Publicado: (2022)

Inhibition of the precursor and mature forms of HIV-1 protease as a tool for drug evaluation
por: Humpolíčková, Jana, et al.
Publicado: (2018)

Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery
por: Kryštůfek, Robin, et al.
Publicado: (2021)

A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism
por: Nijhuis, Monique, et al.
Publicado: (2007)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

HIV Protease: Historical Perspective and Current Research
por: Weber, Irene T., et al.
Publicado: (2021)

Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors
por: Nathan, Bavithra, et al.
Publicado: (2013)

Thermodynamic characterization of the peptide assembly inhibitor binding to HIV-1 capsid protein
por: Kozisek, Milan, et al.
Publicado: (2013)

Inhibitor and Substrate Binding Induced Stability of HIV-1 Protease against Sequential Dissociation and Unfolding Revealed by High Pressure Spectroscopy and Kinetics
por: Ingr, Marek, et al.
Publicado: (2015)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Azanitrile Inhibitors of the SmCB1 Protease Target Are Lethal to Schistosoma mansoni: Structural and Mechanistic Insights into Chemotype Reactivity
por: Jílková, Adéla, et al.
Publicado: (2020)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
por: Viglio, Simona, et al.
Publicado: (2021)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Microbial and fungal protease inhibitors—current and potential applications
por: Sabotič, Jerica, et al.
Publicado: (2012)

Applications of Click Chemistry in the Development of HIV Protease Inhibitors
por: Mudgal, Mukesh M., et al.
Publicado: (2018)

HIV protease inhibitors: a review of molecular selectivity and toxicity
por: Lv, Zhengtong, et al.
Publicado: (2015)

The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes
por: Kryvalap, Yury, et al.
Publicado: (2022)

Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological Targets
por: Bonturi, Camila Ramalho, et al.
Publicado: (2022)

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques
por: Okafor, Sunday N., et al.
Publicado: (2022)

Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers
por: Goda, Jayant S., et al.
Publicado: (2016)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022)

Presence of Protease Inhibitor 9 and Granzyme B in Healthy and Pathological Human Corneas
por: Reinstein Merjava, Stanislava, et al.
Publicado: (2022)

Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
por: Petushkova, Anastasiia I., et al.
Publicado: (2020)

A novel HIV vaccine targeting the protease cleavage sites
por: Li, Hongzhao, et al.
Publicado: (2017)

Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals
por: Trejbalová, Kateřina, et al.
Publicado: (2016)

X-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis
por: Marinović, Maja A., et al.
Publicado: (2022)

Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review
por: Bagnis, Corinne Isnard, et al.
Publicado: (2015)

An Assay to Monitor HIV-1 Protease Activity for the Identification of Novel Inhibitors in T-Cells
por: Hilton, Brett J., et al.
Publicado: (2010)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Proteinaceous cysteine protease inhibitors
por: Dubin, G.
Publicado: (2005)

Mialostatin, a Novel Midgut Cystatin from Ixodes ricinus Ticks: Crystal Structure and Regulation of Host Blood Digestion
por: Kotál, Jan, et al.
Publicado: (2021)

N-Glycosylation can selectively block or foster different receptor–ligand binding modes
por: Vuorio, Joni, et al.
Publicado: (2021)

Evaluation of novel protease inhibitors against darunavir‐resistant variants of HIV type 1
por: Inoue, Mari, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uisvc9spuh9eq60bkl9bi32g9p